The legacy of Viagra and its influence on the pharmaceutical landscape presents a thorny question for shareholders . Initially a blockbuster drug, copycat medications have significantly eroded its market share , creating challenges for companies involved to the original patent holder and similar advancements . While certain companies might profit f